PRKG1 and hearing loss disorder: However, PDE5 inhibitor (vardenafil) has also been demonstrated to protect against noise induced hearing loss (NIHL) through activation of protective cGMP-dependent protein kinase type I (Prkg1) signaling in mouse and rat models (Jaumann et al., 2012).